Long overdue recognition of Klim McPherson’s 1974 article on sequential analysis of trial data JLL Bulletin: commentaries on the history of treatment evaluation

McPherson K . Statistics: the problem of examining accumulation data more than once. N Engl J Med 1974; 290: 501–502. See https://www.jameslindlibrary.org/mcpherson-k-1974/

Armitage P . Sequential tests in prophylactic and therapeutic trials. Quart J Med 1954; 23: 255–274.

Armitage P . Sequential methods in clinical trials. Am J Public Health 1958; 48: 1395–1402.

Armitage P . Sequential Medical Trials. 1st edn. Oxford: Blackwell Scientific Publications, 1960: 1–105. See https://www.jameslindlibrary.org/armitage-p-1960/ (last checked 6 July 2025).

Armitage P McPherson CK Rowe BC . Repeated significance tests on accumulation data. J R Stat Soc 1969; 132: 235–244.

McPherson CK Armitage P . Repeated significance tests on accumulating data when the null hypothesis is not true. J R Stat Soc 1971; 134: 15–25.

Reynolds PS Nagaraja CH . A tribute to Peter Armitage. Chance 2024; 37: 49–54.

Armitage P . Sequential Medical Trials. 2nd edn. Oxford: Blackwell Scientific Publications, 1974: 1–194.

Haybittle JL . Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol 1971; 44(526): 793–797. DOI: 10.1259/0007-1285-44-526-793

O’Brien PC Fleming TR . A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549–556.

Lan KKG DeMets DL . Discrete sequential boundaries for clinical trials. Biometrics 1983; 70: 659–663.

Armitage P . The evolution of ways of deciding when clinical trials should stop recruiting. Journal of the Royal Society of Medicine 2013; 107: 34–39. See https://www.jameslindlibrary.org/articles/the-evolution-of-ways-of-deciding-when-clinical-trials-should-stop-recruiting/ (last checked 6 July 2025).

Peto R Pike MC Armitage P Breslow NE Cox DR Howard SV , et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34: 585–612. See https://www.jameslindlibrary.org/peto-r-pike-mc-armitage-p-breslow-ne-cox-dr-howard-sv-mantel-n-mcpherson-k-peto-j-smith-pg-1976/ (last checked 6 July 2025).

U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Adaptive Designs for Clinical Trials of Drugs and Biologics. Guidance for Industry. FDA 1998; 1-33. See https://www.fda.gov/media/78495/download.

European Medicines Agency. ICH E9: Statistical Principles for Clinical Trials (CPMP/ICH/363/96). Committee for Proprietary Medicinal Products (CPMP), London, 1998. See https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e9-statistical-principles-clinical-trials-step-5_en.pdf (last checked 6 July 2025).

Cytel Inc. EAST® (Version 6.6). Software for the design, simulation, and monitoring of clinical trials. Cambridge, MA: Cytel Inc., 2023. See https://cytel.com/east-horizon/

Pogue J Yusuf S . Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998; 351: 47–52.

Thorlund K Wetterslev J Brok J Gluud C . Trial sequential analyses of six meta-analyses considering heterogeneity and trial weight. Cochrane Colloquium, Melbourne, Australia, 2005. See https://abstracts.cochrane.org/2005-melbourne/trial-sequential-analyses-six-meta-analyses-considering-heterogeneity-and-trial (last checked 6 July 2025).

Wetterslev J Thorlund K Brok J Gluud C . Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 2008; 61:64–75.

Wetterslev J Thorlund K Brok J Gluud C . Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Med Res Methodol 2009; 86: 1–12.

Thorlund K Devereaux PJ Wetterslev J Guyatt G Ioannidis JP Thabane L , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol 2009; 38: 276–286.

Imberger G Gluud C Boylan J Wetterslev J . Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection. Anesth Analg 2015; 121: 1611–1622.

Imberger G Thorlund K Gluud C Wetterslev J . False positive findings in cumulative meta-analysis with and without application of trial sequential analysis: an empirical review. BMJ Open 2016; 6: e011890. See https://www.jameslindlibrary.org/imberger-g-thorlund-k-gluud-c-wetterslev-j-2016/ (last checked 6 July 2025).

Thorlund K Engstrøm J Wetterslev J Brok J Imberger G Gluud C . User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark, 2017. See www.ctu.dk/tsa. Accessed 6 July, 2025.

Thorlund K Engstrøm J Wetterslev J Gluud C . Java Trial Sequential Analysis software ver. 0.9.5.10 Beta, 2021. See http://www.ctu.dk/tsa/forfree. (last checked 6 July 2025).

Thomas J Askie LM Berlin JA , et al. Chapter 22: Prospective approaches to accumulating evidence [last updated October 2019]. In: Higgins JPT Thomas J Chandler J Cumpston M Li T , et al. (eds.) Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024. See cochrane.org/handbook (last checked 6 July, 2025).

Montori VM Devereaux PJ Adhikari NKJ Burns KEA Eggert CH Briel M , et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005; 294; 17: 2203–2209. See https://www.jameslindlibrary.org/montori-vm-devereaux-pj-adhikari-nk-burns-ke-eggert-ch-briel-m-lacchetti-c-leung-tw-darling-e-bryant-dm-bucher-hc-schunemann-hj-meade-mo-cook-dj-erwin-pj-sood-a-sood-r-lo-b-thompson/ (last checked 6 July 2025).

Mills E Cooper C Wu P Rachlis B Singh S Guyatt GH Randomized trials stopped early for harm in HIV/AIDS: a systematic survey. HIV Clin Trials 2006; 7: 24–33. DOI: 10.1310/FEED-6T8U-0BUG-6HQH.

Fleming TR DeMets DL Roe MT Wittes J Calis KA Vora AN , et al. Data monitoring committees: promoting best practices to address emerging challenges. Clin Trials 2017; 14: 115–123. DOI: 10.1177/1740774516688915.

Schöffski P . Importance and role of independent data monitoring committees (IDMCs) in oncology clinical trials. BMJ Open 2021; 11: e047294. DOI: 10.1136/bmjopen-2020-047294.

Ciolino JD Kaizer AM Bonner LB . Guidance on interim analysis methods in clinical trials. J Clin Trans Sci 2023; 7: e124. DOI: 10.1017/cts.2023.552.

Bodden D Hilgers R-D König F . Randomization in clinical trials with small sample sizes using group sequential designs. PLoS One 2025; 20: e0325333. DOI: 10.1371/journal.pone.0325333.

Expert Panel Consensus Statement. Should Cochrane apply error-adjustment methods when conducting repeated meta-analyses? 2017. See https://methods.cochrane.org/sites/methods.cochrane.org/files/uploads/tsa_expert_panel_guidance_and_recommendation_final.pdf (last checked 6 July 2025).

Riberholt CG Olsen MH Milan JB Hafliðadóttir SH Svanholm JH Pedersen EB , et al. Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses: the METSA systematic review. BMC Med Res Methodol 2024; 24: 196. DOI: 10.1186/s12874-024-02318-y